Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications

References

• Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of the genetic thrombophilia in women with complications of pregnancy. N Eng J Med 1999;340:9–13.
   PubMed Web of Science ®Google Scholar
• Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Regan L, et al. Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006;132:171–196.
   PubMed Web of Science ®Google Scholar
• Rodger MA. Thrombophilia and placenta-mediated pregnancy complications: from the bench to bedside to policy. Thromb Res 2009;123 (Suppl 2):S100–S104.
   Google Scholar
• Rodger MA, Paidas M, McLintock C, Middeldorp S, Kahn S, Martinelli I, Hague W, Rosene Montella K, Greer I. Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 2008;112:320–324.
   PubMed Web of Science ®Google Scholar
• Sergio F, Maria Clara D, Gabriella F, Giorgia S, Sara De Carolis, Giancarlo P, Alessendro C. Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone. Hypertens Pregnancy 2006;25:115–127.
   PubMed Web of Science ®Google Scholar
• Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, Scarselli GF, Gensini GF, Abbate R. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 2005;45:86–91.
   PubMed Web of Science ®Google Scholar
• Surkan PJ, Stephansson O, Dickman PW, Cnattingius S. Previous preterm and small-for-gestational-age births and the subsequent risk of stillbirth. N Engl J Med 2004;350:777–785.
   PubMed Web of Science ®Google Scholar
• Rey E, Garneau P, David M, Gauthier R, Leduc L, Michon N, Morin F, Demers C, Kahn SR, Magee LA, Rodger M. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost 2009;7:58–64.
   PubMed Web of Science ®Google Scholar
• Gris JC, Mercier E, Quéré I, Lavigne-Lissalde G, Cochery-Nouvellon E, Hoffet M, Ripart-Neveu S, Tailland ML, Dauzat M, Marès P. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004;103:3695–3699.
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Marozio L, Frusca T, Grandone E, Venturini P, Tiscia GL, Zatti S, Benedetto C. Maternal thrombophilia and the risk of recurrence of preeclampsia. Am J Obstet Gynecol 2009;200:46.e1–46.e5.
   Web of Science ®Google Scholar
• Grandone E, De Stefano V, Rossi E, Cappucci F, Colaizzo D, Margaglione M. Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants. Blood Coagul Fibrinolysis 2008;19:226–230.
   PubMed Web of Science ®Google Scholar
• Kupferminc Michael. Thrombophilia and adverse pregnancy outcome. 9th congress of Perinatal Medicine, Berlin, parallel session 11 Thrombophilia and pregnancy. J Perinat Med 2009;37 (Suppl 1):1–957.
   PubMedGoogle Scholar
• Many A, Schreiber L, Rosner S, Lessing JB, Eldor A, Kupferminc MJ. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol 2001;98:1041–1044.
   PubMed Web of Science ®Google Scholar
• Mousa HA, Alfirevic Z. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Hum Reprod 2000;15:1830–1833.
   PubMed Web of Science ®Google Scholar
• Arias F, Romero R, Joist H, Kraus FT. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med 1998;7:277–286.
   PubMedGoogle Scholar
• Kupferrminc MJ, Fait G, Many A, Lessing JB, Yair D, Bar-Am A, Eldor A. Low molecular weight heparin for the prevention of obstetric complications in women with thrombophilia. Hypertens Pregnancy 2001;20:35–44.
   PubMedGoogle Scholar
• Riyazi N, Leeda M, de Vries JI, Huijgens PC, van Geijn HP, Dekker GA. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Eur J Obstet Gynecol Reprod Biol 1998;80:49–54.
   PubMed Web of Science ®Google Scholar
• Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES. Birth weight standards in the live-born population in Israel. Isr Med Assoc J 2005;7:311–314.
   PubMed Web of Science ®Google Scholar
• Carp H, Dolitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost 2003;1:433–438.
   PubMed Web of Science ®Google Scholar
• Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS. Gestational outcomein thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost 2000;83:693–697.
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–799.
   PubMed Web of Science ®Google Scholar
• Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 2008;112:359–372.
   PubMed Web of Science ®Google Scholar
• Barker DJ. Fetal programming of coronary heart disease. Trends Endocrinol Metab 2002;13:364–368.
   PubMed Web of Science ®Google Scholar
• Ojeda NB, Grigore D, Alexander BT. Intrauterine growth restriction: fetal programming of hypertension and kidney disease. Adv Chronic Kidney Dis 2008;15:101–106.
   PubMedGoogle Scholar
• Pallotto EK, Kilbride HW. Perinatal outcome and later implications of intrauterine growth restriction. Clin Obstet Gynecol. 2006;49:257–269.
   PubMed Web of Science ®Google Scholar
• Spinillo A, Stronati M, Ometto A, Fazzi E, Lanzi G, Guaschino S. Infant neurodevelopmental outcome in pregnancies complicated by gestational hypertension and intra-uterine growth retardation. J Perinat Med 1993;21:195–203.
   PubMed Web of Science ®Google Scholar